UBS AM’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-44,324
| Closed | -$247K | – | 2662 |
|
|
2024
Q4 | $247K | Buy |
44,324
+2,925
| +7% | +$16.3K | ﹤0.01% | 2625 |
|
|
2024
Q3 | $448K | Sell |
41,399
-6,253
| -13% | -$67.6K | ﹤0.01% | 2668 |
|
|
2024
Q2 | $1M | Buy |
47,652
+15,574
| +49% | +$327K | ﹤0.01% | 2369 |
|
|
2024
Q1 | $1.02M | Buy |
32,078
+8,490
| +36% | +$270K | ﹤0.01% | 2003 |
|
|
2023
Q4 | $478K | Hold |
23,588
| – | – | ﹤0.01% | 2332 |
|
|
2023
Q3 | $300K | Buy |
23,588
+13,439
| +132% | +$171K | ﹤0.01% | 2435 |
|
|
2023
Q2 | $174K | Hold |
10,149
| – | – | ﹤0.01% | 2586 |
|
|
2023
Q1 | $174K | Buy |
+10,149
| New | +$174K | ﹤0.01% | 2586 |
|
|
2022
Q4 | – | Sell |
-26,894
| Closed | -$216K | – | 2622 |
|
|
2022
Q3 | $216K | Buy |
26,894
+13,712
| +104% | +$110K | ﹤0.01% | 2584 |
|
|
2022
Q2 | $92K | Hold |
13,182
| – | – | ﹤0.01% | 2654 |
|
|
2022
Q1 | $199K | Hold |
13,182
| – | – | ﹤0.01% | 2682 |
|
|
2021
Q4 | $289K | Buy |
+13,182
| New | +$289K | ﹤0.01% | 2684 |
|